Cure My Disease

Don't miss your cure!

 Log in / Sign up

New inhaled treatment could slow ALS progression

NCT ID NCT07142291

Recruiting now Disease control Sponsor: PhenoNet, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an inhaled medication called PHENOGENE-1A (cromolyn) can help slow the progression of ALS when added to standard treatment. Researchers will enroll 105 adults with mild to moderate ALS to receive either the study drug or a placebo for 24 weeks. The main goals are to see if the treatment improves physical function and breathing ability, and to monitor safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS (ALS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centrum Medyczne NeuroProtect (NeuroProtect Medical Center)

    RECRUITING

    Warsaw, 01-684, Poland

  • Charité Centrum für Neurologie, Neurochirurgie und Psychiatrie

    RECRUITING

    Berlin, 13353, Germany

  • City Clinic Research

    RECRUITING

    Warsaw, 02-473, Poland

  • DIAKOVERE Henriettenstift - Klinik für Neurologie und Klinische Neurophysiologie

    RECRUITING

    Hanover, 30171, Germany

  • Honor Health Neurology - Bob Bove Neuroscience Institute

    RECRUITING

    Scottsdale, Arizona, 85251, United States

  • Hospital Universitario Ramon Y Cajal

    RECRUITING

    Madrid, 28034, Spain

  • Hospital Universitario Vall D Hebron

    RECRUITING

    Barcelona, 8035, Spain

  • Lange Neurology

    RECRUITING

    New York, New York, 10065, United States

  • Mayo Clinic Jacksonville

    RECRUITING

    Jacksonville, Florida, 32224, United States

  • Michalski i Partnerzy Lekarze Spółka Partnerska

    RECRUITING

    Krakow, 31-426, Poland

  • NEUROHK s.r.o.

    RECRUITING

    Hradec Králové, 50002, Czechia

  • SP ZOZ Szpital Uniwersytecki w Krakowie

    RECRUITING

    Krakow, 51-503, Poland

  • Sutter Health - California Pacific Medical Center Research Institute

    RECRUITING

    San Francisco, California, 94115, United States

  • Thomayer University Hospital - Fakultni Thomayerova nemocnice

    RECRUITING

    Prague, 14059, Czechia

  • Universitaetsklinikum Schleswig-Holstein

    RECRUITING

    Lübeck, 23538, Germany

  • University Clinical Center of Serbia

    RECRUITING

    Belgrade, 11000, Serbia

  • University of California San Diego

    RECRUITING

    La Jolla, California, 92037, United States

Conditions

Explore the condition pages connected to this study.

AMYOTROPHIC LATERAL SCLEROSIS (ALS)